February 17, 2018 4:51 PM ET

Pharmaceuticals

Company Overview of Sanofi-Aventis U.S. LLC

Company Overview

Sanofi-Aventis U.S. LLC is a healthcare company that discovers, develops, produces, and markets therapeutic solutions focused on patients’ needs in the United States. The company researches, develops, and brings to market healthcare products and treatments for cardiovascular diseases, oncology, sleep disorder, thrombosis, allergy and respiratory illness, diabetes, central nervous system, internal medicine, metabolic disorders, osteoporosis, and hypertension. It offers prescription products, vaccines and biologics, and other products. The company was founded in 1999 and is headquartered in Bridgewater, New Jersey. Sanofi-Aventis U.S. LLC operates as a subsidiary of Sanofi.

55 Corporate Drive

Bridgewater, NJ 08807

United States

Founded in 1999

Phone:

908-981-5000

Fax:

908-203-7777

Key Executives for Sanofi-Aventis U.S. LLC

Chief Executive Officer of Canada Operations and President of Canada Operations
Chairman of Chattem and Chief Executive Officer of Chattem
Age: 68
President of U S Science and Medical Affairs
President of North America Pharmaceuticals
Principal Accounting Officer and Vice President of Corporate Accounting
Compensation as of Fiscal Year 2017.

Sanofi-Aventis U.S. LLC Key Developments

Sanofi-Aventis U.S. LLC Presents at 3rd Annual Compliance Congress for Specialty Products, Sep-14-2017 through Sep-15-2017

Sanofi-Aventis U.S. LLC Presents at 3rd Annual Compliance Congress for Specialty Products, Sep-14-2017 through Sep-15-2017. Venue: Doubletree Suites by Hilton, 400 Soldiers Field Road, Boston, MA 02134, United States. Presentation Date & Speakers: Sep-14-2017, Masha Chestukhin, Associate Director, Compliance Officer R&D, IA, FMV. Sep-15-2017, Masha Chestukhin, Associate Director, Compliance Officer R&D, IA, FMV, Peter J. Agnoletto, CPA, Senior Director, US Ethics & Business Integrity.

Sanofi-Aventis U.S. LLC Wins $2,400,000,000.00 Federal Contract

VA National Acquisition Center announced that it has awarded a $2,400,000,000.00 federal modified contract on August 19, 2017 to Sanofi-Aventis U.S. LLC., for "Sanofi Contract Effective 9/15/2017 65IB V797D-70230 Effective 9/15/2017 - 9/14/2022".

Sanofi-Aventis U.S. LLC Presents at BIO International Conference 2017, Jun-22-2017 10:15 AM

Sanofi-Aventis U.S. LLC Presents at BIO International Conference 2017, Jun-22-2017 10:15 AM. Venue: San Diego Convention Center, San Diego, California, United States. Speakers: Kaan Certel, Head of External Innovation, Oncology.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sanofi-Aventis U.S. LLC, please visit www.sanofi.us/l/us/en/index.jsp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.